P/E ratio for Vericel (VCEL)
P/E ratio as of May 2024 (TTM): -177
According to Vericel 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -176.857. At the end of 2022 the company had a P/E ratio of -75.3.
P/E ratio history for Vericel from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -75.3 | -69.36% |
| 2021 | -246 | -155.68% |
| 2020 | 441 | -683.12% |
| 2019 | -75.7 | -0% |
| 2018 | -75.7 | 635.7% |
| 2017 | -10.3 | 304.47% |
| 2016 | -2.54 | -4.41% |
| 2015 | -2.66 | 179.1% |
| 2014 | -0.9530 | 114.49% |
| 2013 | -0.4443 | -71% |
| 2012 | -1.53 | -57.16% |
| 2011 | -3.58 | 18.72% |
| 2010 | -3.01 | 0.8% |
| 2009 | -2.99 | -16.34% |
| 2008 | -3.57 | 9.89% |
| 2007 | -3.25 | -63.01% |
| 2006 | -8.79 | -41.71% |
| 2005 | -15.1 | 27.36% |
| 2004 | -11.8 | 42.36% |
| 2003 | -8.31 | 253.72% |
| 2002 | -2.35 | -52.04% |
| 2001 | -4.90 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Royalty Pharma RPRX | 51.4 | -129.07% | 🇬🇧 UK |
 Neogen NEOG | -104 | -41.24% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.